2.85
price down icon2.06%   -0.06
after-market After Hours: 2.87 0.02 +0.70%
loading
Nautilus Biotechnology Inc stock is traded at $2.85, with a volume of 42,505. It is down -2.06% in the last 24 hours and up +9.62% over the past month. Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
See More
Previous Close:
$2.91
Open:
$2.88
24h Volume:
42,505
Relative Volume:
0.60
Market Cap:
$356.17M
Revenue:
-
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.0638
EPS:
-0.47
Net Cash Flow:
$-54.15M
1W Performance:
+2.33%
1M Performance:
+9.62%
6M Performance:
-3.06%
1Y Performance:
-9.81%
1-Day Range:
Value
$2.81
$2.94
1-Week Range:
Value
$2.734
$3.05
52-Week Range:
Value
$2.19
$3.4547

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Name
Nautilus Biotechnology Inc
Name
Phone
206-333-2001
Name
Address
2701 EASTLAKE AVE EAST, SEATTLE
Name
Employee
164
Name
Twitter
Name
Next Earnings Date
2024-07-30
Name
Latest SEC Filings
Name
NAUT's Discussions on Twitter

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-06-22 Initiated Morgan Stanley Equal-Weight
Nov-02-21 Initiated Cowen Outperform
Aug-04-21 Initiated Goldman Neutral
Jul-13-21 Initiated Jefferies Buy

Nautilus Biotechnology Inc Stock (NAUT) Latest News

pulisher
Sep 29, 2024

Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Sep 29, 2024
pulisher
Sep 25, 2024

Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com Canada

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com India

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com UK

Sep 25, 2024
pulisher
Sep 19, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India

Sep 19, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Australia

Sep 18, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com UK

Sep 18, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire

Sep 17, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - StockTitan

Sep 17, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - Yahoo Finance

Sep 17, 2024
pulisher
Sep 11, 2024

Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St

Sep 11, 2024
pulisher
Sep 07, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat

Sep 07, 2024
pulisher
Aug 18, 2024

Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance

Aug 18, 2024
pulisher
Aug 16, 2024

XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan

Aug 14, 2024
pulisher
Aug 14, 2024

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Yahoo Finance

Aug 14, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Jul 31, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey

Jul 31, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha

Jul 30, 2024
pulisher
Jul 30, 2024

NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Down on Releasing Q2 Numbers - Baystreet.ca

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - StockTitan

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - Yahoo Finance

Jul 30, 2024
pulisher
Jul 27, 2024

We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Simply Wall St

Jul 27, 2024
pulisher
Jul 24, 2024

Hybrid Software Group PLC Publishes 2024 Interim Report - Yahoo Finance UK

Jul 24, 2024
pulisher
Jul 23, 2024

Nautilus Biotechnology (NAUT) Set to Announce Earnings on Tuesday - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - MarketBeat

Jul 23, 2024
pulisher
Jul 19, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 2.5% - MarketBeat

Jul 19, 2024
pulisher
Jul 19, 2024

Short Interest in Graco Inc. (NYSE:GGG) Rises By 6.2% - Defense World

Jul 19, 2024
pulisher
Jul 19, 2024

Zacks Research Research Analysts Lower Earnings Estimates for Embraer S.A. (NYSE:ERJ) - Defense World

Jul 19, 2024
pulisher
Jul 19, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 2.5% - Defense World

Jul 19, 2024
pulisher
Jul 19, 2024

Analysts Issue Forecasts for IDEAYA Biosciences, Inc.’s Q2 2024 Earnings (NASDAQ:IDYA) - Defense World

Jul 19, 2024
pulisher
Jul 11, 2024

AI-Enabled Biotech - Madrona Venture Group

Jul 11, 2024
pulisher
Jul 11, 2024

Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development - Audacy

Jul 11, 2024
pulisher
Jul 09, 2024

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - GlobeNewswire

Jul 09, 2024
pulisher
Jul 09, 2024

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - Yahoo Finance

Jul 09, 2024
pulisher
Jul 02, 2024

With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future - Yahoo Finance

Jul 02, 2024
pulisher
Jun 28, 2024

Owning 33% in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) means that insiders are heavily invested in the ... - Yahoo New Zealand News

Jun 28, 2024
pulisher
Jun 28, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Coverage Initiated by Analysts at Guggenheim - Defense World

Jun 28, 2024
pulisher
Jun 27, 2024

Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com Australia

Jun 27, 2024
pulisher
Jun 27, 2024

Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com India

Jun 27, 2024
pulisher
Jun 27, 2024

Amerant Bank appoints new Palm Beach Market President By Investing.com - Investing.com

Jun 27, 2024
pulisher
Jun 27, 2024

Guggenheim Initiates Coverage on Nautilus Biotechnology (NASDAQ:NAUT) - MarketBeat

Jun 27, 2024
pulisher
Jun 27, 2024

Guggenheim Initiates Coverage of Nautilus Biotechnology (NAUT) with Buy Recommendation - Nasdaq

Jun 27, 2024

Nautilus Biotechnology Inc Stock (NAUT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):